Scinovex
articleTop 1% cited

Antidepressant effects of ketamine in depressed patients

Biological Psychiatry · 2000 · Vol. 47(4) · pp. 351–354
Robert BermanAngela CappielloAmit AnandDan A. OrenGeorge R. HeningerDennis S. CharneyJohn H. Krystal
Treatment of Major DepressionTryptophan and brain disordersFunctional Brain Connectivity StudiesPlaceboNMDA receptorAntidepressantKetamineKetamine hydrochlorideDepression (economics)AntagonistSalineAnesthesiaPathophysiology

MeSH terms

AdultAntidepressive AgentsDepressive Disorder, MajorMajor Depressive DisorderDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansInjections, IntravenousKetamineMaleMiddle AgedPsychiatric Status Rating ScalesSeverity of Illness IndexReceptors, N-Methyl-D-Aspartate
Citations
3,787
FWCI
15.42
field-weighted impact
References
28
Percentile
99%
vs. same field & year
Citations per year
Cited by
Ketamine for chronic pain: risks and benefits
British Journal of Clinical Pharmacology · 2013 · 486 citations
Ketamine use: a review
Addiction · 2011 · 631 citations
Overview of glutamatergic neurotransmission in the nervous system
Pharmacology Biochemistry and Behavior · 2011 · 314 citations
Glutamate receptor ion channels
Current Opinion in Neurobiology · 2005 · 3,657 citations
References
Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man
Clinical Pharmacology & Therapeutics · 1965 · 747 citations
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
Archives of General Psychiatry · 1994 · 3,315 citations
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
European Journal of Pharmacology · 1990 · 776 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.